Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $664.38 billion, total revenue of $168.84 billion and a weighted average PE ratio of 38.21.
Market Cap
664.38B
Revenue
168.84B
Profits
17.39B
PE Ratio
38.21
Profit Margin
10.30%
Dividend Yield
0.24%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 176.23B | 0.89% | 2,284,812 | 44.56B |
| 2 | DHR | Danaher Corporation | 133.90B | -0.40% | 5,685,382 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 45.96B | -0.45% | 764,978 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 31.45B | -0.40% | 4,402,164 | 7.07B |
| 5 | WAT | Waters Corporation | 29.33B | -0.19% | 1,980,521 | 3.17B |
| 6 | IQV | IQVIA Holdings Inc. | 28.18B | -0.24% | 3,462,025 | 16.31B |
| 7 | NTRA | Natera, Inc. | 27.28B | -3.67% | 2,362,582 | 2.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 24.48B | 1.18% | 233,261 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 21.67B | -0.41% | 818,798 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.48B | 0.57% | 2,030,094 | 11.04B |
| 11 | EXAS | Exact Sciences Corporation | 20.03B | 0.95% | 21,561,523 | 3.25B |
| 12 | ILMN | Illumina, Inc. | 19.01B | -1.79% | 2,663,205 | 4.34B |
| 13 | MEDP | Medpace Holdings, Inc. | 12.84B | -1.82% | 581,293 | 2.53B |
| 14 | GH | Guardant Health, Inc. | 11.17B | -4.38% | 2,400,949 | 982.02M |
| 15 | RVTY | Revvity, Inc. | 9.61B | 0.21% | 1,429,698 | 2.86B |
| 16 | QGEN | Qiagen N.V. | 8.66B | -1.77% | 2,137,145 | 2.09B |
| 17 | ICLR | ICON Public Limited Company | 7.61B | 1.68% | 1,373,879 | 8.10B |
| 18 | CRL | Charles River Laboratories International, Inc. | 7.56B | 0.36% | 808,584 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 4.77B | -1.84% | 1,227,374 | 2.04B |
| 20 | SHC | Sotera Health Company | 3.84B | -0.44% | 5,592,895 | 1.16B |
| 21 | BLLN | BillionToOne, Inc. | 3.49B | 2.70% | 238,912 | 305.11M |
| 22 | TWST | Twist Bioscience Corporation | 2.58B | -6.09% | 1,338,780 | 391.56M |
| 23 | VCYT | Veracyte, Inc. | 2.53B | -2.87% | 3,203,365 | 517.15M |
| 24 | WGS | GeneDx Holdings Corp. | 2.05B | -4.33% | 660,607 | 427.54M |
| 25 | GRAL | GRAIL, Inc. | 1.92B | -3.36% | 1,199,706 | 147.17M |
| 26 | NEO | NeoGenomics, Inc. | 1.03B | -2.69% | 3,309,251 | 727.33M |
| 27 | CDNA | CareDx, Inc. | 878.36M | -2.50% | 1,041,472 | 379.81M |
| 28 | OPK | OPKO Health, Inc. | 859.83M | -4.27% | 4,523,202 | 606.88M |
| 29 | PSNL | Personalis, Inc. | 759.63M | 0.97% | 1,915,064 | 69.65M |
| 30 | CSTL | Castle Biosciences, Inc. | 743.28M | -2.72% | 294,082 | 344.23M |
| 31 | BNR | Burning Rock Biotech Limited | 503.88M | 5.93% | 15,670 | 77.14M |
| 32 | FLGT | Fulgent Genetics, Inc. | 484.39M | -0.32% | 846,922 | 322.67M |
| 33 | MYGN | Myriad Genetics, Inc. | 428.27M | -3.58% | 17,564,469 | 824.50M |
| 34 | PRE | Prenetics Global Limited | 330.17M | -7.23% | 119,680 | 92.39M |
| 35 | MDXH | MDxHealth SA | 156.41M | -3.07% | 84,136 | 107.88M |
| 36 | BDSX | Biodesix, Inc. | 146.64M | -8.74% | 91,883 | 88.50M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 122.11M | 7.65% | 166,826 | 4.40M |
| 38 | FONR | FONAR Corporation | 120.49M | -0.05% | 65,604 | 106.03M |
| 39 | XGN | Exagen Inc. | 66.87M | -6.40% | 382,084 | 66.58M |
| 40 | PRPO | Precipio, Inc. | 48.85M | 3.53% | 19,048 | 22.80M |
| 41 | BIAF | bioAffinity Technologies, Inc. | 12.28M | -8.08% | 14,527,987 | 6.16M |
| 42 | MBAI | Check-Cap Ltd. | 11.88M | -2.40% | 45,251 | - |
| 43 | NOTV | Inotiv, Inc. | 10.20M | -21.12% | 1,266,007 | 514.03M |
| 44 | XWEL | XWELL, Inc. | 7.09M | 0.82% | 275,848 | 29.52M |
| 45 | ADVB | Advanced Biomed Inc. | 4.49M | -1.07% | 19,227 | - |
| 46 | NDRA | ENDRA Life Sciences Inc. | 4.02M | 5.83% | 19,153 | - |
| 47 | ISPC | iSpecimen Inc. | 1.92M | -1.51% | 2,799,194 | 3.35M |